Disruption of this regulatory balance has been implicated in several gastrointestinal disorders, including inflammatory bowel disease, celiac disease, colorectal cancer, and malabsorption syndromes, where altered CYP24A1 activity may compromise epithelial barrier function, immune modulation, and nutrient transport. This evidence concerns the gene CYP24A1 and digestive system disorder.